Corporate Update – Phio Pharmaceuticals Corp (PHIO)
Phio Pharmaceuticals Corp (ticker PHIO) closed its most recent trading session down 2.46 % at USD 0.87 on Friday, 23 October 2026 (12:08 PM Central Europe). The stock is currently trading at a price that reflects a market capitalization of USD 10.4 million, based on a share supply of 11.6 million.
Trading Volume and Historical Context
- 24‑hour trading volume: approximately USD 46.8 k.
- Month‑to‑date change: the share price has decreased 14.41 % since the end of the previous month.
- Moving average (200 days): USD 1.10.
- 52‑week range:
- High: USD 4.19 (11 March 2025).
- Low: USD 0.81 (2 May 2026).
Comparison with Peer Securities (Last 24 Hours)
| Company | Ticker | 24‑hr change | Current price (USD) | Market cap (USD mn) | Key Corporate Action |
|---|---|---|---|---|---|
| Cellectar Biosciences | CLRB | -8.59 % | 1.17 | 12.1 | — |
| Equus Total Return | EQS | -5.81 % | 0.81 | 12.0 | Update on shareholding structure; voting‑rights holdings fell below 10 % threshold, remaining within regulatory limits. |
| Offerpad | OPAD | 0 % | 2.52 | 11.8 | — |
| Veea | VEEA | -1 % | 4.19 | 12.4 | — |
| Sintx | SINT | -5.75 % | 1.64 | 12.4 | — |
Company Profile
Phio Pharmaceuticals Corp is a biotechnology company listed on the Nasdaq stock exchange. The firm specializes in cancer immunotherapy and also develops treatments for other diseases. Its operations are focused on the United States and are categorized under the Health Care sector. Further information can be found on its website: www.phiopharma.com .